You are a nurse and are participating in your normal clinical rotation at a hospital emergency department (ED) in a rural area. It is a typical afternoon shift when suddenly a large group of patients start flooding into the ED exhibiting symptoms of acute poisoning. The emergency team quickly determines that the cause is an organophosphate disaster. Patients are presenting with symptoms of organophosphate poisoning. What would you expect these symptoms to be and what would you expect the pharmacological interventions to be?

Rationale: A. Organophosphate poisoning causes pinpoint pupils (miosis), not dilated pupils. Although the excessive secretions and respiratory distress are consistent with cholinergic toxicity, adenosine is used for cardiac arrhythmias and does not treat organophosphate poisoning or reverse acetylcholine buildup. B. The symptoms listed are consistent with organophosphate poisoning; however, amiodarone is an antiarrhythmic medication and does not address the underlying cause of toxicity. It does not reverse acetylcholinesterase inhibition or cholinergic effects. C. Organophosphate poisoning inhibits acetylcholinesterase, leading to excessive acetylcholine and a cholinergic crisis. This results in symptoms such as miosis, bronchoconstriction, increased secretions, and respiratory distress. Atropine works by blocking muscarinic receptors and reducing secretions and bronchospasm, while pralidoxime (2-PAM) reactivates acetylcholinesterase and reverses the underlying toxicity. D. Although the symptoms are correct, adenosine is not used in the treatment of organophosphate poisoning and does not counteract cholinergic toxicity.